Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003121290 | SCV003785620 | likely benign | not provided | 2023-11-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004244616 | SCV004915108 | uncertain significance | Inborn genetic diseases | 2024-01-02 | criteria provided, single submitter | clinical testing | The c.865C>T (p.R289C) alteration is located in exon 6 (coding exon 6) of the CACNA1G gene. This alteration results from a C to T substitution at nucleotide position 865, causing the arginine (R) at amino acid position 289 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV003121290 | SCV005392562 | uncertain significance | not provided | 2024-05-03 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Department of Pathology and Laboratory Medicine, |
RCV005356352 | SCV005920085 | uncertain significance | Spinocerebellar ataxia type 42 | 2021-11-24 | criteria provided, single submitter | research |